HomeAI · summaries
Storia in 2 fonti
Revolution Medicines' potential breakthrough pancreatic cancer drug succeeds in late-stage trial
Revolution Medicines' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
cnbc.com
Former Sen. Ben Sasse shines the spotlight on a possible breakthrough for pancreatic cancer
Former Sen. Ben Sasse is taking Revolution Medicines' daraxonrasib, which has shown promise as a treatment for pancreatic cancer.
- ·
Revolution Medicines' potential breakthrough pancreatic cancer drug succeeds in late-stage trial
Revolution Medicines' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial.
- ·
wired.it
Il farmaco sperimentale daraxonrasib per il tumore del pancreas ha raddoppiato la sopravvivenza in uno studio clinico di fase III
Assunto per via orale una volta al giorno, il farmaco potrebbe fornire una promettente nuova opzione di trattamento ai pazienti con una delle neoplasie più letali